NASD · Healthcare · Medical Instruments & Supplies · USA
Nexgel Inc is a micro cap company (market value under $300 million) in the Medical Instruments & Supplies industry.
Nexgel manufactures hydrogel products using electron beam cross-linking technology for applications in wound treatment, diagnostics, drug delivery patches, and skincare. The company supplies custom gels to third-party manufacturers as a contract manufacturer, sells branded consumer products directly to end users, and offers white label solutions. Nexgel also develops medical devices to reduce skin irritation at device-skin interfaces.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Nexgel Inc stock.
Undervalued: intrinsic value $5.75 per share, market price $3.80, margin of safety 33.9% (as of 2026-11-17).
A 1.5x revenue multiple, discounted for its losses, values the shares at $5.75; the price of $3.80 is 34% below that value.
All 52 Medical Instruments & Supplies stocks
NXGL is undervalued (as of the 2026-11-17 close). A 1.5x revenue multiple, discounted for its losses, values the shares at $5.75; the price of $3.80 is 34% below that value.
$5.75 per share (as of the 2026-11-17 close), against a market price of $3.80. That is a margin of safety of 33.9%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.